ASXC Asensus Surgical Market Cap to Net Assets Ratio

Official company branding of asensus.com (ASXC)

The current price-to-book ratio reflects the results of Asensus Surgical, Inc. (ASXC) shifting its strategy toward the implementation of AI systems under the guidance of a new investor, with the value recorded at -8.75. Senhance technologies ensure steady demand due to their haptic feedback. However, high debt and the slow adoption of robots by physicians create significant obstacles to the business's profitability.

ASXC asensus.com: Market Value to Book Value in the range 07/04/2022 - 08/31/2024
Original product of Asensus Surgical, Inc.

When constructing a long-term portfolio, it is critical to assess the extent of the overpayment for the issuer's net assets. This indicator measures the market value premium over book capital, revealing the level of speculative optimism. For Asensus Surgical, Inc. (ASXC), with a current value of -8.75, this metric reflects the market's belief in the success of AI platforms against medtech giants. Patent protection and the accessibility of procedures create the foundation for this valuation. By analyzing the market capitalization-to-book ratio, an investor can timely identify signs of asset overheating.

Competitor analysis

DXCM (DexCom, Inc.) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|PROF - Market Cap to Book Value Multiple|bairdmed.com - Market Capitalization to Book Value Ratio|EDAP TMS (EDAP) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio APYX|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Pulmonx Corporation (LUNG) - Market Cap to Net Assets Ratio|Market Value to Book Value TELA (telabio.com)|CytoSorbents Corporation - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Sensus Healthcare Inc SRTS|ZYXI (Zynex Inc) - Market Capitalization to Book Value Ratio|ECOR - Market-to-Book Ratio|Market Capitalization to Book Value Ratio vicarioussurgical.com|Inspira Technologies (IINN) - Capitalization to Book Value Ratio|ICU: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRIDEX Corp.|Market Capitalization to Book Value Ratio INBS (Intelligent Bio Solutions)|Market Cap to Net Assets Ratio beyondair.net (XAIR)|Market Capitalization to Book Value Ratio PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Market Capitalization to Book Value Ratio|GCTK - Market Value to Book Value Ratio|nanovibronix.com (NAOV) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Venus Concept Corp VERO|Nuwellis Corp (NUWE) - Market Value to Book Value|Market Capitalization to Book Value Ratio AEMD (Aethlon Medical)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)